JB Chemicals & Pharmaceuticals discloses cessation of Nikhil Chopra as CEO and KMP effective March 31, 2026.
Chopra had earlier resigned as Whole-time Director effective January 21, 2026, citing personal reasons and other professional opportunities.
Disclosure filed under Regulation 30 of SEBI LODR Regulations, 2015 and SEBI Master Circular dated November 11, 2024.